Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2025-12-24 @ 7:44 PM
NCT ID:
NCT00261703
Brief Summary:
Primary Objective:
* Phase II: To determine the best treatment scheme (TPF vs. PF).
* Phase III: To compare the time to progression and the treatment failure at the 3 arms.
Secondary objectives:
* To evaluate the safety at the 3 arms.
* To compare the progression , overall survival and locoregional control at the 3 arms.
Study:
NCT00261703
Study Brief:
Protocol Section:
NCT00261703